According to Scholar Rock Holding's latest financial reports the company's current earnings (TTM) are -$0.17 B. In 2022 the company made an earning of -$0.14 B a decrease over its 2021 earnings that were of -$0.14 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$0.17 B | 23.26% |
2022 | -$0.14 B | 2.05% |
2021 | -$0.14 B | 52.4% |
2020 | -$86.49 M | 69.57% |
2019 | -$51 M | 3.39% |
2018 | -$49.33 M | 97.35% |
2017 | -$25 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Organovo ONVO | -$19.09 M | -88.49% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | -$73.07 M | -55.93% | ๐ฌ๐ง UK |
Novavax NVAX | -$0.53 B | 218.85% | ๐บ๐ธ USA |
Novocure
NVCR | -$0.19 B | 13.65% | Jersey |